CC
CRBU icon

Corton Capital’s Caribou Biosciences CRBU Stock Holding History

Corton Capital’s Portfolio CRBU Stock Details CRBU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-13,654
Closed -$70.2K – 546
2024
Q1 		$70.2K Buy
13,654
+905
+7% +$5.58K 0.03% 487
2023
Q4 		$73.1K Buy
+12,749
New +$63K 0.02% 555

Other funds holding CRBU

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
EWM
Elmwood Wealth Management Berkeley, California $400M AUM 17.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Corton Capital's CRBU Position: Q2 2024 in Review

Corton Capital sold out of Caribou Biosciences (CRBU) in Q2 2024, closing a stake of 13,654 shares — an estimated $70.2K sold.

Corton Capital first reported a position in CRBU in Q4 2023 and held it in 2 quarters. The position peaked at $73.1K in Q4 2023. 140 funds tracked by Wall St. Rank hold CRBU as of Q2 2024.

  • Corton Capital reported no remaining Caribou Biosciences position as of Q2 2024 after selling out during the quarter.
  • Corton Capital sold 13,654 Caribou Biosciences shares in Q2 2024, an estimated $70.2K.
  • Corton Capital first reported a position in Caribou Biosciences in Q4 2023 and held it in 2 quarters.
  • Corton Capital's Caribou Biosciences position peaked at $73.1K in Q4 2023.
  • 140 funds tracked by Wall St. Rank held Caribou Biosciences as of Q2 2024.

Based on Corton Capital's 13F filing for Q2 2024, filed 14 Aug 2024.